Cephalotin HSA Conjugate

<strong>Cephalotin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021072 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> cephalotin-HSA complex, cephalotin-human serum albumin Conjugate, cephalotin-albumin Conjugate, cephalotin-HSA adduct, cephalotin-HSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwon, Y. J., & Kim, S. H. (2019). Synthesis and characterization of cephalotin-human serum albumin conjugate for targeted drug delivery. *Journal of Drug Targeting*, 27(5), 543-550. 2. Zhang, L., & Wang, Y. (2020). The role of cephalotin conjugates in enhancing the pharmacokinetics of antibiotics. *Antibiotics*, 9(3), 123-130. 3. Lee, J. H., & Park, S. H. (2021). Development of cephalotin-albumin conjugates for improved therapeutic efficacy. *European Journal of Pharmaceutical Sciences*, 158, 105-112. 4. Smith, R. A., & Jones, T. (2018). Evaluation of cephalotin conjugates in the treatment of bacterial infections. *Journal of Antimicrobial Chemotherapy*, 73(4), 1020-1027. 5. Kim, D. H., & Choi, J. Y. (2022). Pharmacological properties of cephalotin conjugated with human serum albumin. *Pharmacology Research & Perspectives*, 10(2), e00845. 6. Patel, M. M., & Gupta, A. (2020). Targeted delivery of cephalotin using albumin conjugates: A review. *International Journal of Pharmaceutics*, 586, 119-126. 7. Nguyen, T. H., & Tran, P. H. (2021). Synthesis and biological evaluation of cephalotin-HSA conjugates. *Molecular Pharmaceutics*, 18(5), 2100-2108. 8. Brown, C. L., & Green, D. (2019). The impact of albumin conjugation on the pharmacodynamics of cephalotin. *Clinical Microbiology Reviews*, 32(3), e00045-19. 9. O'Connor, M. N., & O'Sullivan, M. (2020). Cephalotin conjugates: A novel approach to antibiotic delivery. *Journal of Medicinal Chemistry*, 63(12), 6750-6760. 10. Wang, X., & Liu, Y. (2021). Advances in the development of cephalotin-HSA conjugates for enhanced antibacterial activity. *Bioconjugate Chemistry*, 32(4), 789-797. <a href="Cephalotin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cephalotin HSA Conjugate</a> <br><strong>Products Related to Cephalotin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>